CAPSAICIN 8% PATCH (Qutenza®)

Clinical Indication

Diabetic neuropathy

Date of classification

February 2016

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.